APA

Jasmin J., Mercier I., Dupuis J., Tanowitz H. B. & Lisanti M. P. (20060918). Short-term administration of a cell-permeable caveolin-1 peptide prevents the development of monocrotaline-induced pulmonary hypertension and right ventricular hypertrophy. : Circulation.

Chicago

Jasmin Jean-François, Mercier Isabelle, Dupuis Jocelyn, Tanowitz Herbert B and Lisanti Michael P. 20060918. Short-term administration of a cell-permeable caveolin-1 peptide prevents the development of monocrotaline-induced pulmonary hypertension and right ventricular hypertrophy. : Circulation.

Harvard

Jasmin J., Mercier I., Dupuis J., Tanowitz H. B. and Lisanti M. P. (20060918). Short-term administration of a cell-permeable caveolin-1 peptide prevents the development of monocrotaline-induced pulmonary hypertension and right ventricular hypertrophy. : Circulation.

MLA

Jasmin Jean-François, Mercier Isabelle, Dupuis Jocelyn, Tanowitz Herbert B and Lisanti Michael P. Short-term administration of a cell-permeable caveolin-1 peptide prevents the development of monocrotaline-induced pulmonary hypertension and right ventricular hypertrophy. : Circulation. 20060918.